Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo
Dongyu Duan,1,* Aiping Wang,1,* Ling Ni,2 Liping Zhang,1 Xiuju Yan,1 Ying Jiang,1 Hongjie Mu,1 Zimei Wu,1 Kaoxiang Sun,1 Youxin Li1,2 1School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Phar...
Saved in:
Main Authors: | Duan D, Wang A, Ni L, Zhang L, Yan X, Jiang Y, Mu H, Wu Z, Sun K, Li Y |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/88974bc7fbb946cda3d1d1be33ff2a79 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leucemia Aguda Infantil en la Xª Región Clasificación FAB y Factores Epidemiológicos
by: Zolezzi R,Paola, et al.
Published: (1985) -
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment
by: Bi CC, et al.
Published: (2016) -
Reversible cardiotoxicity in a 54-year-old woman treated with trastuzumab
by: Martins,Sandro José, et al.
Published: (2012) -
Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells
by: Rodríguez-Serrano F, et al.
Published: (2016) -
Review of Curcumin Physicochemical Targeting Delivery System
by: Li L, et al.
Published: (2020)